 | Up a level |
Damonti, Lauro; Gasser, Michael; Kronenberg, Andreas; Buetti, Niccolò (2024). Epidemiology of bloodstream infections caused by extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae in Switzerland, 2015-2022: secular trends and association with the COVID-19 pandemic. The journal of hospital infection, 150, pp. 145-152. Elsevier 10.1016/j.jhin.2024.05.013
Kronenberg, Andreas; Gasser, Michael; Plüss-Suard, Catherine; Friedli, Olivier; Leib, Stephen (2024). Für einen besseren Umgang mit Antibiotika. Schweizerische Ärztezeitung, 105(04), pp. 29-33. EMH Schweizerischer Ärzteverlag AG 10.4414/saez.2024.1288111951
Renggli, L; Plüss-Suard, C; Gasser, M; Sonderegger, B; Kronenberg, A (2023). Assessing the conversion of electronic medical record data into antibiotic stewardship indicators. The journal of antimicrobial chemotherapy, 78(9), pp. 2297-2305. Oxford University Press 10.1093/jac/dkad235
Renggli, Luzia; Gasser, Michael; Buetti, Niccolò; Kronenberg, Andreas (2023). Increase in methicillin-susceptible Staphylococcus aureus bloodstream infections in Switzerland: a nationwide surveillance study (2008-2021). Infection, 51(4), pp. 1025-1031. Springer 10.1007/s15010-023-01980-6
Gasser, Michael; Cassini, Alessandro; Lo Fo Wong, Danilo; Gelormini, Marcello; Nahrgang, Saskia Andrea; Zingg, Walter; Kronenberg, Andreas Oskar (2023). Associated deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in Switzerland, 2010 to 2019. Eurosurveillance, 28(20) European Centre for Disease Prevention and Control 10.2807/1560-7917.ES.2023.28.20.2200532
Voellmy, Irene Katharina; Lang, Claudia; Gasser, Michael; Kronenberg, Andreas (2022). Antibiotic resistance surveillance of Klebsiella pneumoniae complex is affected by refined MALDI-TOF identification, Swiss data, 2017 to 2022. Eurosurveillance, 27(45) European Centre for Disease Prevention and Control 10.2807/1560-7917.ES.2022.27.45.2200104
Friedli, Olivier; Gasser, Michael; Cusini, Alexia; Fulchini, Rosamaria; Vuichard-Gysin, Danielle; Halder Tobler, Roswitha; Wassilew, Nasstasja; Plüss-Suard, Catherine; Kronenberg, Andreas (2022). Impact of the COVID-19 Pandemic on Inpatient Antibiotic Consumption in Switzerland. Antibiotics, 11(6) MDPI 10.3390/antibiotics11060792
Renggli, L.; Gasser, M.; Plüss-Suard, C.; Harbarth, S.; Kronenberg, A. (2022). Temporal and structural patterns of extended-spectrum cephalosporin-resistant Klebsiella pneumoniae incidence in Swiss hospitals. Journal of hospital infection, 120, pp. 36-42. Elsevier 10.1016/j.jhin.2021.11.006
Renggli, L.; Gasser, M.; Plüss-Suard, C.; Kronenberg, A. (2021). Consumption of anti-meticillin-resistant Staphylococcus aureus antibiotics in Swiss hospitals is associated with antibiotic stewardship measures. The journal of hospital infection, 117, pp. 165-171. Elsevier 10.1016/j.jhin.2021.08.019
Barnsteiner, Stefanie; Baty, Florent; Albrich, Werner C; Babouee Flury, Baharak; Gasser, Michael; Plüss-Suard, Catherine; Schlegel, Matthias; Kronenberg, Andreas; Kohler, Philipp (2021). Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018. Eurosurveillance, 26(46) European Centre for Disease Prevention and Control 10.2807/1560-7917.ES.2021.26.46.2001537
Sommerstein, Rami; Damonti, Lauro; Marschall, Jonas; Harbarth, Stephan; Gasser, Michael; Kronenberg, Andreas; Buetti, Niccolò (2021). Distribution of pathogens and antimicrobial resistance in ICU-bloodstream infections during hospitalization: a nationwide surveillance study. Scientific reports, 11(1), p. 16876. Springer Nature 10.1038/s41598-021-95873-z
Ramette, Alban; Gasser, Michael; Nordmann, Patrice; Zbinden, Reinhard; Schrenzel, Jacques; Perisa, Damir; Kronenberg, Andreas (2021). Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018. Eurosurveillance, 26(15) European Centre for Disease Prevention and Control 10.2807/1560-7917.ES.2021.26.15.1900760
Damonti, Lauro; Kronenberg, Andreas; Marschall, Jonas; Jent, Philipp; Sommerstein, Rami; De Kraker, Marlieke E. A.; Harbarth, Stephan; Gasser, Michael; Buetti, Niccolò (2021). The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study. Critical care, 25(1), p. 403. BioMed Central 10.1186/s13054-021-03814-z
Renggli, Luzia; Gasser, Michael; Frey, Pascal M.; Kronenberg, Andreas (2020). Bekämpfung von Antibiotikaresistenzen in der Schweiz. Primary and Hospital Care, 20(11), pp. 352-355. EMH Swiss Medical Publishers Ltd. 10.4414/phc-d.2020.10319
Piezzi, Vanja; Gasser, Michael; Atkinson, Andrew; Kronenberg, Andreas; Vuichard-Gysin, Danielle; Harbarth, Stephan; Marschall, Jonas; Buetti, Niccolò (2020). Increasing proportion of vancomycin-resistance among enterococcal bacteraemias in Switzerland: a 6-year nation-wide surveillance, 2013 to 2018. Eurosurveillance, 25(35) European Centre for Disease Prevention and Control 10.2807/1560-7917.ES.2020.25.35.1900575
Gasser, Michael; Zingg, Walter; Cassini, Alessandro; Kronenberg, Andreas (2019). Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in Switzerland. Lancet infectious diseases, 19(1), pp. 17-18. Elsevier 10.1016/S1473-3099(18)30708-4
Gasser, Michael; Schrenzel, J; Kronenberg, Andreas Oskar (2018). Aktuelle Entwicklung der Antibiotikaresistenzen in der Schweiz. Swiss Medical Forum, 18(46), pp. 943-949. EMH Swiss Medical Publishers 10.4414/smf.2018.03404
Rothen-Rutishauser, Barbara; Kuhn, Dagmar; Ali, Zulqurnain; Gasser, Michael; Amin, Faheem; Parak, Wolfang J.; Vanhecke, Dimitri; Fink, Alke; Gehr, Peter; Brandenberger, Stefanie Christina (2014). Quantification of gold nanoparticle cell uptake under controlled biological conditions and adequate resolution. Nanomedicine, 9(5), pp. 607-621. Future Medicine 10.2217/nnm.13.24
Gasser, Michael; Rothen-Rutishauser, Barbara; Krug, Harald F; Gehr, Peter; Nelle, Mathias; Yan, Bing; Wick, Peter (2010). The adsorption of biomolecules to multi-walled carbon nanotubes is influenced by both pulmonary surfactant lipids and surface chemistry. Journal of nanobiotechnology, 8, p. 31. London: BioMed Central 10.1186/1477-3155-8-31
